ORION PHARMA, UAB

Company age: 19 y. 3 mo.

Update

Company overview

Basic information

Company name ORION PHARMA, UAB
Company code 300868868
VAT code LT100003291319
Registered address Vilnius, Ukmergės g. 126, LT-08100
Registration date 2007-06-08 Company age: 19 y. 3 mo.

Contact information

Phone Phone
Email Email
Website https://www.orionpharma.lt

Indicators

Revenue (2025) 1,485,680 € -6% History
Profit (2025) 82,936 € -18% History
Share capital 14,480 €
Number of employees 9 History
Average salary 4562 € History
Managed vehicles 8 List
Employee turnover rate 11,2 % History

Risk factors

Current SODRA debt No debt Read more
Days of debt to SODRA per year 0 days
Current VMI debt No debt Read more
Financial statements All submitted

Activity

Legal form Private Limited Liability Company
NACE activity Activities of advertising agencies
Sector Užsienio subjektų kontroliuojamos ne finansų bendrovės
Ownership form Private foreign capital

Download a detailed company report

Make confident decisions with all the information about ORION PHARMA, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report

Description

This description was generated by artificial intelligence.
ORION PHARMA, UAB (company code 300868868) is an operational private limited liability company registered in 2007 and based in Vilnius, at Ukmerges g. 126, Vilniaus m. sav., Vilniaus apskr. The company is classified as a private, non-financial business controlled by foreign entities, with governance described as CEO with board/council. It operates in the advertising sector under EVRK code N.73.11.00, Activities of advertising agencies. The company is classified as micro-sized and its authorised capital is EUR 14.5K.

Financially, ORION PHARMA generated revenue of EUR 1.49M in 2025, compared with EUR 1.58M in 2024 and EUR 1.56M in 2023. Net profit was EUR 82.9K in 2025, down from EUR 101.2K in 2024 and EUR 111.4K in 2023, while the profit margin declined from 7.2% in 2023 to 6.4% in 2024 and 5.6% in 2025. At the end of 2025, equity stood at EUR 98.9K, liabilities at EUR 185.6K, and total assets at EUR 373.8K. The latest available workforce figure so far in 2026 shows an average of 8 employees, down from 9 in 2025, while the average monthly wage increased to EUR 6,277.40 from EUR 5,231.05 in 2025.